Kidney Toxicity


Fri, 19 Feb 2016
Design of new multi-target drugs: Case studies with neuroprotective and anti-inflammatory agents
In the last two decades, drug discovery has focused mainly on single-target approach ('one disease - one target'). This strategy has however failed in many cases; in fact, no disease-modifying agents have been marketed for the treatment of many multifactorial diseases, such as neurodegenerative and inflammatory diseases. ... more »